Financhill
Back

Entrada Therapeutics 10K Form

Buy
64

TRDA
Entrada Therapeutics

Last Price:
19.31
Seasonality Move:
-34.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TRDA News And Ratings

See the #1 stock for the next 7 days that we like better than TRDA

TRDA Financial Statistics

Sales & Book Value

Annual Sales: $129.01M
Cash Flow: $38.79M
Price / Cash Flow: 0
Annual Sales: $11.57
Price / Book: 1.61

Profitability

EPS (TTM): 2.96000
Net Income (TTM): $104.44M
Gross Margin: --
Return on Equity: 37.43%
Return on Assets: 20.55%

Entrada Therapeutics Earnings Forecast

Key Entrada Therapeutics Financial Ratios

  • The Research & Development expenses have been 77.42% of Revenue.
  • The Net Earning history of TRDA is -5.18% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Entrada Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TRDA
Website: entradatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.7
Quick Ratio: 5.56

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TRDA Technical Analysis vs Fundamental Analysis

Buy
64
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy or a Sell?